Aardvark Therapeutics, Inc. Common Stock (AARD) vs BGM Group Ltd. (BGM)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and BGM Group Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.11HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
BGM
BGM Group Ltd.
$8.61HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
Total return — AARD vs BGM
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)BGM -97.0% (-82.7%/yr)AARD compounded faster over this window
Log scale — wide-divergence pair
AARD BGM
AARD vs BGM: by the numbers
- •AARD is the larger company ($112M vs $109M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -52.59% net margin).
Metrics side by side
Valuation
| Metric | AARD | BGM |
|---|---|---|
| P/B ratio | 1.49 | 0.27 |
Profitability
| Metric | AARD | BGM |
|---|---|---|
| Gross margin | 0.00% | 12.79% |
| Operating margin | 0.00% | -33.18% |
| Net margin | 0.00% | -52.59% |
| ROE | -93.44% | -5.10% |
| ROIC | -97.99% | -3.19% |
Growth (annualized)
| Metric | AARD | BGM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -5.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.